Abstract

BackgroundDapoxetine hydrochloride is a selective serotonin reuptake inhibitor drug for treating premature ejaculation. This study was designed to develop and validate a sensitive and selective LC–MS/MS method for trace analysis of genotoxic impurity ethyl methanesulfonate in Dapoxetine hydrochloride.ResultsChromatographic separation was achieved on the Shodex RSpak DS-413 column, 150 × 4.6 mm, 3.0 µm using eluent containing a equal volumes of acetonitrile and 0.1% v/v formic acid in water was used in the isocratic elution mode at a pump flow of 1.0 mL/min. No interference was observed at the retention time of ethyl methanesulfonate, indicating that the developed method is specific and selective for trace level quantification.The developed method was found to be linear in the concentration range of 1–50 ppm with coefficient of regression of 0.9997. Detection limit and quantification limit were determined to be 0.6 ppm and 1.0 ppm respectively. Acceptable RSD values (< 10.0%) and recovery results (> 90%) obtained from the accuracy and precison experiments indicate that the developed method is precise and accurate in the concentration range of 1–50 ppm. Ethyl methanesulfonate solutions were stable for two days when stored at room and refrigerated temperatures.ConclusionThe developed method has the ability to quantify ethyl methanesulfonate in dapoxetine hydrochloride. Thus, the anticipated method has high probability to adopt in the quality testing laboratories of pharmaceutical industry.

Highlights

  • Dapoxetine hydrochloride is a selective serotonin reuptake inhibitor drug for treating premature ejaculation

  • Optimization of liquid chromatographic and mass spectrometric method conditions In the development of a Liquid chromatography (LC)–Mass spectrometer (MS)/MS method for quantification of Ethyl methanesulfonate (EMS) in Dapoxetine hydrochloride (DAPO), first the LC conditions were optimized followed by the mass spectrometric conditions

  • Optimizaion of LC conditions was done based on elution time of EMS and DAPO, peak area of EMS and resolution between EMS and DAPO

Read more

Summary

Introduction

Dapoxetine hydrochloride is a selective serotonin reuptake inhibitor drug for treating premature ejaculation. A drug substance can contain different types of trace-level impurities. The ICH M7 recommended limits for daily intake of GTIs are 120, 20, 10 and < 1.5 μg/day, for < 1 m onth, > 1–12 months, > 1- 10 years and > 10 years to lifetime, respectively. Based on the maximum daily dose (MDD) of the drug substance, limit for the quantitation of mutagenic impurities will be established. Dapoxetine hydrochloride (DAPO) is a novel short acting selective serotonin reputake inhibitor drug for treating premature ejaculation (PE) and depression [3]. Presence of any GTIs in the DAPO can further aggravate the side effects of the drug in patients receiving drug prodcuts containing DAPO. It is very important to identify and quantify any GTIs that could be present in DAPO

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call